Abstract
The anti-bacterial properties of lauric acid (LA) and its glycerides had been studied. However, their effects on gut microbiota remain unclear. Moreover, LA and its glycerides performed controversial influences on lipid metabolism. This study evaluated the regulation of LA, glycerol monolaurate (GML) and lauric triglyceride (GTL) on metabolic health and gut microbiota in high fat diet-fed mice. Serum metabolomics and lipidomics contributed to elucidate the underlying mechanisms. LA and its glycerides ameliorated hyperlipidemia, while GML performed more pronounced modulation on glucose metabolism and inflammation. LA and its glycerides modulated gut microbiota with increased Bifidobacterium and decreased Desulfovibrio, which closely related with metabolic improvements. Furthermore, the integrative multi-omics analyses identified that the regulation of phospholipid metabolism, intestinal microbial metabolites (bile acids and indole derivatives) and endogenous unsaturated fatty acids synthesis conduced to the more evident modulation of GML. Our findings suggested an effective strategy of GML for improving metabolism and gut health.
Full text
